TABLE 1.

Correlation of different IL-17A⁺ cell subsets with the clinicopathological characteristics of NSCLC.

Features	N	Subsets (n = 15)
		Th17 (Mean ± SEM %)	p Value	Tc17 (Mean ± SEM %)	p Value	γδT17 (Mean ± SEM %)	p Value
Gender
Male	8	7.18 ± 1.18	0.51	6.24 ± 0.71	0.87	10.02 ± 1.56	0.16
Female	7	8.56 ± 1.64		6.46 ± 1.08		13.06 ± 1.28
Age
<61	6	6.10 ± 1.40	0.61	5.86 ± 1.01	0.55	11.48 ± 2.29	0.97
≥61	9	7.30 ± 1.47		6.69 ± 0.86		11.41 ± 1.07
Smoking
Yes	5	8.73 ± 2.45	0.59	6.00 ± 1.00	0.71	10.44 ± 2.39	0.52
No	10	7.39 ± 1.19		6.54 ± 0.85		11.94 ± 1.14
Tumor size (cm)
<4	8	7.02 ± 1.41	0.89	6.96 ± 0.84	0.55	12.52 ± 1.41	0.30
≥4	7	7.29 ± 1.31		6.18 ± 0.95		10.21 ± 1.6
Lymphatic metastasis
Yes	7	8.89 ± 1.33	0.19	7.20 ± 1.11	0.23	14.77 ± 1.04	<0.001***
No	8	6.20 ± 1.39		5.62 ± 0.67		8.52 ± 0.92
CYFRA 21-1 (ng/ml)
<3.3	8	5.423 ± 0.79	0.06	5.639 ± 0.75	0.24	8.91 ± 0.91	<0.01**
>3.3	7	8.79 ± 1.47		7.18 ± 1.05		14.40 ± 1.39
CEA (ng/ml)
≤5	9	7.66 ± 1.20	0.79	6.77 ± 0.86	0.45	11.01 ± 0.97	0.64
>5	6	8.25 ± 1.91		5.74 ± 0.99		12.08 ± 2.36